secwatch.observer — SEC 8-K summary
======================================

Issuer:     MBX Biosciences, Inc. (MBX)
CIK:        0001776111
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001193125-24-219621
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MBX Biosciences adopts amended charter and bylaws in connection with IPO
------------------------------------------------------------------------

- Fourth amended and restated certificate of incorporation filed; authorizes 500M shares of common stock.
- Authorizes 10M shares of undesignated preferred stock with board authority to issue in series.
- Eliminates all references to prior series of preferred stock from earlier charter.
- Amended and restated bylaws establish advance notice procedures for stockholder proposals and director nominations.
- Changes effective immediately prior to IPO consummation as previously disclosed in S-1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1776111/000119312524219621/0001193125-24-219621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1776111/000119312524219621/d888081d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-219621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer